Elsevier

Neuropharmacology

Volume 61, Issue 8, December 2011, Pages 1366-1378
Neuropharmacology

Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method

https://doi.org/10.1016/j.neuropharm.2011.08.023Get rights and content

Abstract

Cholinergic receptors have been implicated in schizophrenia, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. However, to better target therapeutically the appropriate receptor subsystems, we need to understand more about the functions of those subsystems. In the current series of experiments, we assessed the functional role of M1 receptors in cognition by testing M1 receptor-deficient mice (M1R−/−) on the five-choice serial reaction time test of attentional and response functions, carried out using a computer-automated touchscreen test system. In addition, we tested these mice on several tasks featuring learning, memory and perceptual challenges. An advantage of the touchscreen method is that each test in the battery is carried out in the same task setting, using the same types of stimuli, responses and feedback, thus providing a high level of control and task comparability. The surprising finding, given the predominance of the M1 receptor in cortex, was the complete lack of effect of M1 deletion on measures of attentional function per se. Moreover, M1R−/− mice performed relatively normally on tests of learning, memory and perception, although they were impaired in object recognition memory with, but not without an interposed delay interval. They did, however, show clear abnormalities on a variety of response measures: M1R−/− mice displayed fewer omissions, more premature responses, and increased perseverative responding compared to wild-types. These data suggest that M1R−/− mice display abnormal responding in the face of relatively preserved attention, learning and perception.

Highlights

► We examined the functional role of the M1 receptor in cognition. ► We report abnormal responding of M1 knockout mice in the touchscreen 5-CSRTT. ► M1R−/− mice were unimpaired in touchscreen learning, memory, and perception tasks. ► M1R−/− mice were impaired at object recognition memory with a delay. ► M1R is involved in distinct aspects of cognition.

Introduction

It is widely acknowledged that our attempts at developing pro-cholinergic treatments for diseases affecting cognition – schizophrenia, Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, to name just a few (Bartus et al., 1982, Coyle et al., 1983, Eglen et al., 1999, Felder et al., 2000, Friedman, 2004, Wess, 2004, Youdim and Buccafusco, 2005) – have been met with limited success. One possible reason for this lack of success is our lack of understanding of the specific functional roles of the various subtypes of cholinergic receptors (Gainetdinov and Caron, 1999). To target treatments to the critical cholinergic subsystem associated with disease, we must first understand the functions of these subsystems. With respect to diseases involving changes in cognition, many authors have emphasized specifically the importance of the muscarinic (M1–M5) receptor subsystem (Bymaster et al., 2002, Langmead et al., 2008, Wess, 2004). In the present study we focused on the functional role of the M1 receptor, as M1 receptors have been repeatedly implicated in normal cognition, as well as in all of the diseases mentioned above (Dean et al., 2003, Fisher, 2008, Wess et al., 2007).

One aspect of cognitive function with which the cholinergic system has been repeatedly associated is attention (Passetti et al., 2000, Robbins, 1997, Sarter and Bruno, 2000), which can effectively be assessed in rodents using the 5-choice serial reaction time task (5-CSRTT). This task provides measures of sustained attentional function, and also measures of abnormal responding, for example premature and perseverative responses (thought to model impulsivity and compulsivity, respectively) (Carli et al., 1983, Robbins, 2002). Non-selective muscarinic receptor antagonists impair attentional function in rodents performing the 5-CSRTT when given either systemically (Humby et al., 1999, Jones and Higgins, 1995, Mirza and Stolerman, 2000, Pattij et al., 2007) or when infused directly into prefrontal cortex (Chudasama et al., 2004, Dalley et al., 2004, Muir et al., 1996). However, little is known about which specific muscarinic receptor subtypes are involved in this task. As the M1 receptor is the predominant muscarinic receptor in cortex (Flynn et al., 1995, Levey et al., 1991), we speculated that this receptor might play an important role in attention as measured by the 5-CSRTT.

M1 knockout (M1R−/−) mice are an ideal model for investigating the role of these receptors in cognition, as there is a paucity of agents with which to target these receptors selectively, and the knockout mice do not show any gross behavioral or morphological abnormalities, making them well-suited to cognitive testing (Wess, 2004, Wess et al., 2007). Furthermore, several studies have indicated that disruption of one specific muscarinic receptor gene does not have major effects on the levels of the four remaining muscarinic receptors (Hamilton et al., 1997). In the present study, therefore, we trained M1R−/− mice and wild-type (M1R+/+) controls on a touchscreen version of the 5-CSRTT, and assessed their performance under a number of behavioral challenge conditions, as well as on several additional tests of cognition using the same touchscreen apparatus, and on a spontaneous object recognition test using 3-dimensional objects.

Section snippets

Experiment 1: 5-CSRTT

In experiment 1 we examined the performance of M1R−/− mice and wild-type controls (M1R+/+) in a touchscreen version of the 5-CSRTT. This task has been indispensable for investigating the neuropsychological mechanisms involved in diseases and disorders that manifest attentional dysfunction (e.g., attention deficit/hyperactivity disorder (ADHD), AD, Parkinson’s disease, schizophrenia, and addiction) (Carli et al., 1983, Chudasama and Robbins, 2004, Dalley et al., 2007, Dalley et al., 2001, Dalley

Accuracy

When the stimulus duration was reduced to 0.8 s, accuracy levels were significantly reduced in both genotypes. A two-way ANOVA with repeated measures conducted on the stimulus duration (2.0 s, 1.5 s, and 0.8 s) revealed no significant effect of genotype (F < 1) and no significant interaction of stimulus duration by genotype (F < 1). There was a significant main effect of stimulus duration (F(2,26) = 10.87, p = 0.001) (see accuracy graph, Fig. 2A).

Omissions

By decreasing the stimulus duration, omissions

Discussion

The present study sought to clarify the role of M1 receptors in cognition by examining the performance of M1R−/− mice on the 5-CSRTT of attentional and response functions, in addition to several tasks featuring learning, memory and perceptual challenges. A major, surprising finding, given the predominance of the M1 receptor in cortex, was the complete lack of effect of M1 deletion on measures of attentional function per se. Specifically, M1R−/− mice showed not greater, but fewer omissions

Acknowledgments

This work was supported by a Wellcome Trust Project Grant and an Alzheimer’s Research Trust grant to T.J.B. and L.M.S. S.J.B. was additionally supported by a Ruth L. Kirschstein Predoctoral Fellowship from the National Institutes of Mental Health.

References (72)

  • R.M. Ridley et al.

    Stimulus-bound perseveration after frontal ablations in marmosets

    Neuroscience

    (1993)
  • R.M. Ridley

    The psychology of perserverative and stereotyped behaviour

    Prog. Neurobiol.

    (1994)
  • T.W. Robbins

    Arousal systems and attentional processes

    Biol. Psychol.

    (1997)
  • J. Sandson et al.

    Varieties of perseveration

    Neuropsychologia

    (1984)
  • M.L. Woolley et al.

    Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice

    Eur. J. Pharmacol.

    (2009)
  • N. Amitai et al.

    Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats

    Psychopharmacology (Berl)

    (2007)
  • S.G. Anagnostaras et al.

    Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

    Nat. Neurosci.

    (2003)
  • S.J. Bartko et al.

    Perceptual functions of perirhinal cortex in rats: zero-delay object recognition and simultaneous oddity discriminations

    J. Neurosci.

    (2007)
  • Bartko, S.J., Winters, B.D., Wess, J., Mattson, M.P., Saksida, L.M., Bussey, T.J., 2008. The role of cholinergic...
  • S.J. Bartko et al.

    A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil

    Psychopharmacology (Berl)

    (2011)
  • A. Bari et al.

    The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats

    Nat. Protoc.

    (2008)
  • R.T. Bartus et al.

    The cholinergic hypothesis of geriatric memory dysfunction

    Science

    (1982)
  • J.L. Brigman et al.

    Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit

    Learn. Mem.

    (2008)
  • T.J. Bussey et al.

    Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat

    Behav. Neurosci.

    (1997)
  • T.J. Bussey et al.

    Discrimination of computer-graphic stimuli by mice: a method for the behavioral characterization of transgenic and gene-knockout models

    Behav. Neurosci.

    (2001)
  • T.J. Bussey et al.

    The touchscreen cognitive testing method for rodents: how to get the best out of your rat

    Learn. Mem.

    (2008)
  • F.P. Bymaster et al.

    Muscarinic receptors as a target for drugs treating schizophrenia

    Curr. Drug Targets CNS Neurol. Disord.

    (2002)
  • Y. Chudasama et al.

    Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia

    Psychopharmacology (Berl)

    (2004)
  • Y. Chudasama et al.

    Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine

    Learn. Mem.

    (2004)
  • J.T. Coyle et al.

    Alzheimer’s disease: a disorder of cortical cholinergic innervation

    Science

    (1983)
  • J.W. Dalley et al.

    Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task

    J. Neurosci.

    (2001)
  • J.W. Dalley et al.

    Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex

    Cereb. Cortex

    (2004)
  • J.W. Dalley et al.

    Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance

    Neuropsychopharmacology

    (2005)
  • J.W. Dalley et al.

    Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine

    Neuropsychopharmacology

    (2007)
  • S. Dasari et al.

    M1 and M4 receptors modulate hippocampal pyramidal neurons

    J. Neurophysiol.

    (2011)
  • B. Dean et al.

    Muscarinic receptors in schizophrenia

    Curr. Mol. Med.

    (2003)
  • Cited by (0)

    View full text